Association between exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers prior to septic shock and acute kidney injury;Asociación entre la exposición previa a inhibidores de la enzima conversora de la angiotensina y los antagonistas de los receptores de la angiotensina en pacientes con fracaso renal agudo y shock séptico

Medicina Intensiva

Volumn 41, Issue 1, 2017, Pages 21-27

  Suberviola, B ^a   Rodrigo, E ^a   Gonzalez Castro A ^a   Serrano, M ^a   Heras, M ^a   Castellanos Ortega, A ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Acute kidney injury; Angiotensin receptor blockers; Angiotensin converting enzyme inhibitors; Recovery; Septic shock

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE KIDNEY FAILURE; ADULT; APACHE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EXPOSURE; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE UNIT; KIDNEY FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PROGNOSIS; PROSPECTIVE STUDY; SEPTIC SHOCK; TERTIARY HEALTH CARE; AGED; COMPLICATION; MIDDLE AGED;

ACUTE KIDNEY INJURY; AGED; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SHOCK, SEPTIC;

EID: 85006056392     PISSN: 02105691     EISSN: 15786749     Source Type: Journal    
DOI: 10.1016/j.medin.2016.07.010     Document Type: Article

References (37)

1. 1 Chertow, G.M., Burdick, E., Honour, M., Bonventre, J.V., Bates, D.W., Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16 (2005), 3365–3370.
2. 2 Parikh, A., Shaw, A., The economics of renal failure and kidney disease in critically ill patients. Crit Care Clin. 28 (2012), 99–111.
3. 3 Wang, H.E., Muntner, P., Chertow, G.M., Warnock, D.G., Acute kidney injury and mortality in hospitalized patients. Am J Nephrol. 35 (2012), 349–355.
4. 4 Mandelbaum, T., Scott, D.J., Lee, J., Mark, R.G., Malhotra, A., Waikar, S.S., et al. Outcome of critically ill patients with acute kidney injury using the Acute Kidney Injury Network criteria. Crit Care Med. 39 (2011), 2659–2664.
5. 5 Uchino, S., Kellum, J.A., Bellomo, R., Doig, G.S., Morimatsu, H., Morgera, S., et al., Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294 (2005), 813–818.
6. 6 Bagshaw, S.M., Uchino, S., Bellomo, R., Morimatsu, H., Morgera, S., Schetz, M., et al., Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol 2 (2007), 431–439.
7. 7 Dial, S., Nessim, S.J., Kezouh, A., Benisty, J., Suissa, S., Antihypertensive agents acting on the renin-angiotensin system and the risk of sepsis. Br J Clin Pharmacol 78 (2014), 1151–1158.
8. 8 Johnson, S.A., Spurney, R.F., Twenty years after ACEIs and ARBs: emerging treatment strategies for diabetic nephropathy. Am J Physiol Renal Physiol 309 (2015), F807–F820.
9. 9 Coca, S.G., Garg, A.X., Swaminathan, M., Garwood, S., Hong, K., Thiessen-Philbrook, H., et al., TRIBE-AKI Consortium. Preoperative angiotensin-converting enzyme inhibitors and angiotensin receptor blocker use and acute kidney injury in patients undergoing cardiac surgery. Nephrol Dial Transpl 28 (2013), 2787–2799.
10. 10 Shah, M., Jain, A.K., Brunelli, S.M., Coca, S.G., Devereaux, P.J., James, M.T., et al. Association between angiotensin converting enzyme inhibitor angiotensin receptor blocker use prior to major elective surgery and the risk of acute dialysis. BMC Nephrol., 15, 2014, 53.
11. 11 Plataki, M., Kashani, K., Cabello-Garza, J., Maldonado, F., Kashyap, R., Kor, D.J., et al. Predictors of acute kidney injury in septic shock patients: an observational cohort study. Clin J Am Soc Nephrol. 6 (2011), 1744–1751.
12. 12 National Clinical Guideline Centre (UK), Acute kidney injury: prevention, detection and management up to the point of renal replacement therapy. 2013, August, Royal College of Physicians, London, UK.
13. 13 Castellanos-Ortega, Á., Suberviola, B., García-Astudillo, L.A., Ortiz, F., Llorca, J., Delgado-Rodríguez, M., Late compliance with the sepsis resuscitation bundle: impact on mortality. Shock 36 (2011), 542–547.
14. 14 Levy, M.M., Fink, M.P., Marshall, J.C., Abraham, E., Angus, D., Cook, D., et al. SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31 (2003), 1250–1256.
15. 15 Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., et al., Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 345 (2001), 1368–1377.
16. 16 Kidney Disease Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2 (2012), 1–138.
17. 17 Zeng, X., McMahon, G.M., Brunelli, S.M., Bates, D.W., Waikar, S.S., Incidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals. Clin J Am Soc Nephrol 9 (2014), 12–20.
18. 18 Fujii, T., Uchino, S., Takinami, M., Bellomo, R., Validation of the Kidney Disease Improving Global Outcomes criteria for AKI and comparison of three criteria in hospitalized patients. Clin J Am Soc Nephrol. 9 (2014), 848–854.
19. 19 Ostermann, M., Chang, R.W., Acute kidney injury in the intensive care unit according to RIFLE. Crit Care Med. 35 (2007), 1837–1843.
20. 20 Bentley, M.L., Corwin, H.L., Dasta, J., Drug-induced acute kidney injury in the critically ill adult: recognition and prevention strategies. Crit. Care Med. 38 (2010), S169–S174.
21. 21 Pannu, N., Nadim, M.K., An overview of drug-induced acute kidney injury. Crit. Care Med. 36 (2008), S216–S223.
22. 22 Suh, S.H., Kim, C.S., Choi, J.S., Bae, E.H., Ma, S.K., Kim, S.W., Acute kidney injury in patients with sepsis and septic shock: risk factors and clinical outcomes. Yonsei Med J. 54 (2013), 965–972.
23. 23 Mortensen, E.M., Restrepo, M.I., Copeland, L.A., Pugh, J.A., Anzueto, A., Cornell, J.E., et al. Impact of previous statin and angiotensin II receptor blocker use on mortality in patients hospitalized with sepsis. Pharmacotherapy 27 (2007), 1619–1626.
24. 24 Salgado, D.R., Rocco, J.R., Silva, E., Vincent, J.L., Modulation of the renin-angiotensin-aldosterone system in sepsis: a new therapeutic approach. Expert Opin. Ther. Targets 14 (2010), 11–20.
25. 25 Zhang, W., Chen, X., Huang, L., Lu, N., Zhou, L., Wu, G., et al. Severe sepsis: low expression of the renin-angiotensin system is associated with poor prognosis. Exp Ther Med. 7 (2014), 1342–1348.
26. 26 Kim, W.Y., Huh, J.W., Lim, C.M., Koh, Y., Hong, S.B., Analysis of progression in risk, injury, failure, loss, and end-stage renal disease classification on outcome in patients with severe sepsis and septic shock. J Crit Care. 27 (2012), e1–e7.
27. 27 Poukkanen, M., Vaara, S.T., Pettilä, V., Kaukonen, K.M., Korhonen, A.M., Hovilehto, S., et al., FINNAKI study group. Acute kidney injury in patients with severe sepsis in Finnish Intensive Care Units. Acta Anaesthesiol Scand 57 (2013), 863–872.
28. 28 Horkan, C.M., Purtle, S.W., Mendu, M.L., Moromizato, T., Gibbons, F.K., Christopher, K.B., The association of acute kidney injury in the critically ill and postdischarge outcomes: a cohort study. Crit Care Med. 43 (2015), 354–364.
29. 29 Oppert, M., Engel, C., Brunkhorst, F.M., Bogatsch, H., Reinhart, K., Frei, U., et al., German Competence Network Sepsis (Sepnet). Acute renal failure in patients with severe sepsis and septic shock – a significant independent risk factor for mortality: results from the German Prevalence Study. Nephrol Dial Transpl 23 (2008), 904–909.
30. 30 Mårtensson, J., Bellomo, R., Sepsis-induced acute kidney injury. Crit Care Clin. 31 (2015), 649–660.
31. 31 Sood, M.M., Shafer, L.A., Ho, J., Reslerova, M., Martinka, G., Keenan, S., et al., Cooperative Antimicrobial Therapy in Septic Shock (CATSS) Database Research Group. Early reversible acute kidney injury is associated with improved survival in septic shock. J Crit Care. 29 (2014), 711–717.
32. 32 Castellanos-Ortega, A., Suberviola, B., García-Astudillo, L.A., Holanda, M.S., Ortiz, F., Llorca, J., et al. Impact of the surviving sepsis campaign protocols on hospital length of stay and mortality in septic shock patients: results of a three-year follow-up quasi-experimental study. Crit Care Med. 38 (2010), 1036–1043.
33. 33 Wan, L., Bagshaw, S.M., Langenberg, C., Saotome, T., May, C., Bellomo, R., Pathophysiology of septic acute kidney injury: what do we really know?. Crit. Care Med. 36 (2008), S198–S203.
34. 34 Ahmed, W., Memon, J.I., Rehmani, R., Al Juhaiman, A., Outcome of patients with acute kidney injury in severe sepsis and septic shock treated with early goal-directed therapy in an intensive care unit. Saudi J Kidney Dis Transpl. 25 (2014), 544–551.
35. 35 Mouncey, P.R., Osborn, T.M., Power, G.S., Harrison, D.A., Sadique, M.Z., Grieve, R.D., et al., ProMISe Trial Investigators. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med 372 (2015), 1301–1311.
36. 36 ProCESS Investigators, Yealy, D.M., Kellum, J.A., Huang, D.T., Barnato, A.E., Weissfeld, L.A., Pike, F., et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med 370 (2014), 1683–1693.
37. 37 ARISE Investigators ANZICS Clinical Trials Group, Peake, S.L., Delaney, A., Bailey, M., Bellomo, R., Cameron, P.A., Cooper, D.J., et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med 371 (2014), 1496–1506.